Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Breast Cancer

  Free Subscription

Articles published in Carcinogenesis

Retrieve available abstracts of 21 articles:
HTML format

Single Articles

    November 2022
  1. YIN X, Li G, Fan D, Ge Z, et al
    Ehm2 transcript variant 1 inhibits breast cancer progression and increases E-cadherin stability.
    Carcinogenesis. 2022 Nov 24:bgac076. doi: 10.1093.
    PubMed     Abstract available

    October 2022
  2. ZHAO L, Lei J, Gu S, Zhang Y, et al
    A yes-associated protein 1-Notch1 positive feedback loop promotes breast cancer lung metastasis by attenuating the Bone morphogenetic protein 4-SMAD family member 1/5 signaling.
    Carcinogenesis. 2022 Oct 4. pii: 6748174. doi: 10.1093.
    PubMed     Abstract available

    September 2022
  3. ZHOU LX, Zheng H, Tian Y, Luo KF, et al
    SNCA inhibits epithelial-mesenchymal transition and correlates to favorable prognosis of breast cancer.
    Carcinogenesis. 2022 Sep 30. pii: 6732370. doi: 10.1093.
    PubMed     Abstract available

    August 2022
  4. AITMAGAMBETOVA MA, Smagulova GA, Tuhvatshin RR, Zheksenova AN, et al
    Genetic and clinical characteristics of BRCA-associated hereditary breast cancer in the West region of Kazakhstan.
    Carcinogenesis. 2022 Aug 2. pii: 6653490. doi: 10.1093.
    PubMed     Abstract available

    July 2022
  5. MOU J, Xu X, Wang F, Kong W, et al
    HMGN4 plays a key role in STAT3-mediate oncogenesis of triple-negative breast cancer.
    Carcinogenesis. 2022 Jul 6. pii: 6632630. doi: 10.1093.
    PubMed     Abstract available

    June 2022

  6. Retraction to: 2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression.
    Carcinogenesis. 2022 Jun 22. pii: 6610927. doi: 10.1093.

  7. SUMAN P, Mehta V, Craig AWB, Chander H, et al
    Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion.
    Carcinogenesis. 2022;43:494-503.
    PubMed     Abstract available

    May 2022

  8. Correction to: tRNA-derived fragment tRFLys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PC.
    Carcinogenesis. 2022 May 31. pii: 6596197. doi: 10.1093.

  9. BICER A, Lopez-Henares P, Feu-Llaurado A, Sabariego M, et al
    The PxIxIT motif of the RCAN3 Inhibits angiogenesis and tumor progression in Triple Negative Breast Cancer in Immunocompetent Mice.
    Carcinogenesis. 2022 May 30. pii: 6594970. doi: 10.1093.
    PubMed     Abstract available

  10. LI N, Wang X, Sun J, Liu Y, et al
    miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
    Carcinogenesis. 2022 May 2. pii: 6577054. doi: 10.1093.
    PubMed     Abstract available

    March 2022
  11. ELISIA I, Yeung M, Wong J, Kowalski S, et al
    A low-carbohydrate diet containing soy protein and fish oil reduces breast but not prostate cancer in C3(1)/Tag mice.
    Carcinogenesis. 2022;43:115-125.
    PubMed     Abstract available

    January 2022
  12. CHEN M, Li S, Srinivasasainagendra V, Sharma M, et al
    Maternal soybean genistein on prevention of later-life breast cancer through inherited epigenetic regulations.
    Carcinogenesis. 2022 Jan 27. pii: 6515999. doi: 10.1093.
    PubMed     Abstract available

    December 2021
  13. XU R, Yan Y, Zheng X, Zhang H, et al
    Aspirin Suppresses Breast Cancer Metastasis to Lung by Targeting Anoikis Resistance.
    Carcinogenesis. 2021 Dec 27. pii: 6484923. doi: 10.1093.
    PubMed     Abstract available

  14. PARK J, Huang D, Chang YJ, Lim MC, et al
    Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: A meta-analysis of observational studies.
    Carcinogenesis. 2021 Dec 27. pii: 6484912. doi: 10.1093.
    PubMed     Abstract available

  15. ZENG Q, Jin F, Qian H, Chen H, et al
    The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.
    Carcinogenesis. 2021 Dec 18. pii: 6469523. doi: 10.1093.
    PubMed     Abstract available

  16. HUANG S, Shu X, Ping J, Wu J, et al
    TBX1 functions as a putative oncogene of breast cancer through promoting cell cycle progression.
    Carcinogenesis. 2021 Dec 17. pii: 6469002. doi: 10.1093.
    PubMed     Abstract available

  17. SHLIAKHTUNOU YA, Siamionau VM, Pobyarzhin VV
    Transcription phenotype of circulating tumor cells in non-metastatic breast cancer.
    Carcinogenesis. 2021 Dec 17. pii: 6469006. doi: 10.1093.
    PubMed     Abstract available

    October 2021
  18. AL-JOMAH N, Al-Mohanna FH, Aboussekhra A
    Tocilizumab suppresses the pro-carcinogenic effects of breast cancer- associated fibroblasts through inhibition of the STAT3/AUF1 pathway.
    Carcinogenesis. 2021 Oct 30. pii: 6414472. doi: 10.1093.
    PubMed     Abstract available

  19. CHO BA, Iyengar NM, Zhou XK, Morrow M, et al
    Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome.
    Carcinogenesis. 2021;42:1281-1292.
    PubMed     Abstract available

  20. GODINA C, Khazaei S, Tryggvadottir H, Visse E, et al
    Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: A prospective cohort study.
    Carcinogenesis. 2021 Oct 4. pii: 6380882. doi: 10.1093.
    PubMed     Abstract available

    July 2021
  21. RAHMAN MM, Herath D, Bladen JC, Atkar R, et al
    Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
    Carcinogenesis. 2021;42:975-983.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.